A Phase 2, Stratified, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of MGAWN1 in Subjects with Laboratorydocumented West Nile Fever or Suspected Central Nervous System Infection Due to West Nile Virus.

Trial Profile

A Phase 2, Stratified, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of MGAWN1 in Subjects with Laboratorydocumented West Nile Fever or Suspected Central Nervous System Infection Due to West Nile Virus.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Oct 2010

At a glance

  • Drugs MGAWN1 (Primary)
  • Indications West Nile virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 07 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top